Article Details
Retrieved on: 2021-07-01 16:43:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... that it has signed an agreement to nonexclusively license its CRISPR-Cas9 patent portfolio to the Japanese biotechnology company Nippon Gene.
Article found on: www.genomeweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here